Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Voriconazole can cause serious side effects, especially in long-term use.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Azelaic acid's effectiveness in treating certain skin conditions needs more research.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

Valproic acid is an effective seizure medication with some temporary side effects.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Low dose valproic acid treatment caused hair loss in a young patient.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Compound 4 is a promising treatment for hair loss with low toxicity.

Vitamin E can reduce the negative effects of valproic acid on hair and skin development.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Upadacitinib may cause hair loss.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

The drug combination was safe and showed promise in treating advanced tumors.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.